Cannabis and brain health: what TikTok gets right and wrong

What did @doctor.bing actually say?

In a 4.9 million-view TikTok, @doctor.bing laid out four claims about cannabis and the brain: that it raises stroke and atrial fibrillation risk in people under 50, that it reduces brain volume and disrupts connectivity in regions tied to memory and decision-making, that it increases psychosis and schizophrenia risk, and that prenatal use harms children's cognition. The framing was confident and clinical, the kind of delivery that reads as authoritative. But confident delivery and accurate science are not the same thing, so let's pull the claims apart.

The video doesn't mention dose, frequency, or product type, which matters enormously when talking about cannabis research. A daily high-THC concentrate user and someone who had a few joints at college are not the same study population. That caveat is missing entirely.

Does the science back this up?

Mostly yes, but with important asterisks. The stroke and arrhythmia claims have real data behind them, but the word "significantly" is doing a lot of heavy lifting. The brain volume and psychosis claims reflect legitimate findings in heavy, early-onset users. The prenatal data is genuine but often misrepresented in terms of effect size.

On stroke: a 2019 study by Hackam in Stroke found cannabis use was associated with increased ischemic stroke risk, particularly in younger adults, though the absolute risk increase remains modest. On atrial fibrillation: a 2023 study by Murtaza et al. in the Journal of the American Heart Association found cannabis users had higher AF rates, but confounding factors like tobacco co-use are hard to fully strip out. On brain structure: a 2020 meta-analysis by Yücel et al. in Neuropsychology Review found reduced hippocampal and amygdala volumes in heavy chronic users, with effects most pronounced in adolescent-onset users. On psychosis: Di Forti et al. (2019, Lancet Psychiatry) showed daily high-potency cannabis use was associated with roughly a fivefold increased psychosis risk. That's real. The prenatal data comes largely from the ABCD Study and earlier cohort work, and the associations are real, though effect sizes are often modest once socioeconomic confounders are controlled.

What did they get wrong (or right)?

They got the direction of the evidence right on almost every claim. That matters. These are not invented risks. But there are two problems worth naming plainly.

First, the language of certainty. Saying cannabis "significantly increases" stroke risk without specifying what significantly means, or for what kind of user, compresses a complex literature into a scare headline. The absolute risk increase for stroke in a casual adult user is not the same as in a daily dabber with pre-existing cardiovascular risk factors.

Second, the psychosis claim needs more precision. The elevated risk is real and well-documented, but it is concentrated in people with genetic predisposition and in high-potency, frequent users. Saying it "increases the risk of developing psychosis and schizophrenia" without that context implies a more uniform risk than the evidence supports. Di Forti et al. (2019) showed the association is strongest with high-THC daily use, not moderate or infrequent use.

The brain development point, that the brain continues developing until around 25, is well-supported and legitimately important. That part deserves credit.

What should you actually know?

Cannabis is not a neutral substance, and the risks the creator describes are real for specific populations. Heavy, early-onset, high-potency use is genuinely associated with worse cognitive and psychiatric outcomes. The cardiovascular risks are emerging and worth taking seriously, even if absolute magnitudes are still being refined.

But risk is not destiny, and context matters. The evidence does not support treating a 30-year-old who occasionally uses low-THC cannabis the same way as a teenager using high-potency concentrates daily. If you're in a high-risk group, meaning you're under 25, you have a personal or family history of psychosis, you have cardiovascular risk factors, or you're pregnant, the case for avoidance is genuinely strong based on current evidence.

• Use frequency, age of onset, and THC potency all modify these risks substantially.
• The psychosis association is real but most pronounced in genetically predisposed individuals using high-potency products daily.
• Prenatal exposure data is concerning and the precautionary principle applies here clearly.
• Cardiovascular research on cannabis is newer and still accumulating, but the signal is real enough to take seriously.